De Novo device
Paige Prostate
Paige.Ai · Software Algorithm Device To Assist Users In Digital Pathology (QPN, Class II) · First FDA decision Sep 21, 2021, newest Sep 21, 2021Cancer detection and genomic testingProstate cancer
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
0
Naming "Paige Prostate"
MAUDE reports
0
Brand "Paige Prostate", since 2015
PubMed studies
17
Mentioning "Paige Prostate"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Paige ProstateNew device typeBreakthroughDe Novo
DEN200080 · Decided Sep 21, 2021 · 264 days after receipt
Device type: Software Algorithm Device To Assist Users In Digital Pathology (QPN) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Paige Prostate", any status and sponsor, newest update first.
No registered device study names "Paige Prostate".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Paige Prostate", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QPN
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Paige Prostate"[tiab]. The summary above synthesizes these.
- Artificial intelligence-assisted cancer diagnosis improves the efficiency of pathologists in prostatic biopsies.
Eloy C, Marques A, Pinto J, et al. · Virchows Arch · 2023
- Prospective Clinical Implementation of Paige Prostate Detect Artificial Intelligence Assistance in the Detection of Prostate Cancer in Prostate Biopsies: CONFIDENT P Trial Implementation of Artificial Intelligence Assistance in Prostate Cancer Detection.
Flach RN, van Dooijeweert C, Nguyen TQ, et al. · JCO Clin Cancer Inform · 2025Research Support, Non-U.S. Gov't
- Artificial Intelligence-Enabled Prostate Cancer Diagnosis and Prognosis: Current State and Future Implications.
Satturwar S, Parwani AV · Adv Anat Pathol · 2024
- Review and Commentary on Digital Pathology and Artificial Intelligence in Pathology.
Sirintrapun SJ · JCO Clin Cancer Inform · 2025Review
- Artificial intelligence-driven prostate cancer diagnosis: Enhancing accuracy and personalizing patient care.
Zhang X, Xiao N, Liang H, et al. · Urol Oncol · 2026Review
- Independent real-world application of a clinical-grade automated prostate cancer detection system.
da Silva LM, Pereira EM, Salles PG, et al. · J Pathol · 2021Research Support, Non-U.S. Gov't
- Clinical applications of artificial intelligence in genitourinary pathology.
Li A, Parwani A · Mol Aspects Med · 2026
- Potential of AI and ML in oncology research including diagnosis, treatment and future directions: A comprehensive prospective.
Gupta A, Bajaj S, Nema P, et al. · Comput Biol Med · 2025Review
- Clinical advantages in providing artificial intelligence-assisted prostate cancer diagnosis: A pilot study.
Eloy C, Asaturova A, Pinto J, et al. · Pathol Res Pract · 2025
- An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy.
Perincheri S, Levi AW, Celli R, et al. · Mod Pathol · 2021Research Support, Non-U.S. Gov't
- Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies.
Raciti P, Sue J, Ceballos R, et al. · Mod Pathol · 2020Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code QPN.
- Galen Second ReadIbex Medical Analytics , Ltd. · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.